Delcath Systems (DCTH -48.9%) collapses after the FDA votes unanimously against the company's...

|About: Delcath Systems, Inc. (DCTH)|By:, SA News Editor

Delcath Systems (DCTH -48.9%) collapses after the FDA votes unanimously against the company's Melblez Kit, as the risks purportedly outweigh the benefits. The shares were halted Thursday pending the announcement. DCTH is the second casualty of this week's Oncologic Drugs Advisory Board, as Aveo Pharmaceuticals (AVEO +1.5%) received a similarly disappointing panel vote on Tivozanib. (Background: I, II)